Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Total Debt: 2019-2021

  • CureVac N.V's Total Debt rose 129.35% to $32.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $32.5 million, marking a year-over-year increase of 129.35%. This contributed to the annual value of $30.0 million for FY2020, which is 58.27% down from last year.
  • Per CureVac N.V's latest filing, its Total Debt stood at $32.5 million for Q3 2021, which was up 0.92% from $32.2 million recorded in Q2 2021.
  • CureVac N.V's Total Debt's 5-year high stood at $72.0 million during Q4 2019, with a 5-year trough of -$110.7 million in Q3 2020.
  • Its 3-year average for Total Debt is $11.2 million, with a median of $32.2 million in 2021.
  • Its Total Debt has fluctuated over the past 5 years, first plummeted by 58.27% in 2020, then skyrocketed by 129.35% in 2021.
  • CureVac N.V's Total Debt (Quarterly) stood at $72.0 million in 2019, then crashed by 58.27% to $30.0 million in 2020, then soared by 129.35% to $32.5 million in 2021.
  • Its Total Debt stands at $32.5 million for Q3 2021, versus $32.2 million for Q2 2021 and $30.0 million for Q4 2020.